Biotage

An SPE protocol for the extraction of a range of mycotoxins from dried chili using ISOLUTE® Myco with LC-MS/MS analysis, achieving high recoveries of relevant mycotoxins with %RSDs and LOQs that meet EU regulations for measurement of these analytes.

This application note describes the extraction of nine phthalate metabolites from human urine using ISOLUTE ENV+ solid phase extraction columns. This method demonstrates repeatability, quantitative analyte recovery and minimal matrix suppression for the nine phthalate metabolites tested in urine.

This application note describes a Solid Phase Extraction (SPE) protocol for the extraction of aflatoxin M1 (AM1) internally standardized with aflatoxin B2 (AB2) from infant formula using ISOLUTE® Myco SPE columns with LC MS/MS.

This application note describes the extraction of THC, THCA and Carboxy-THC from oral fluid matrix collected using the Quantisall™ (Immunalysis) device, prior to GC/MS analysis.

This application note describes a polymer based-based strong anion exchange mixed-mode SPE protocol for the extraction of T3, rT3 and T4 from serum prior to LC-MS/MS analysis.

This application note describes effective and efficient ISOLUTE SLE+ protocols optimized for sample loading volumes of either 300 μL or 800 μL.

This application note describes a simple, clean and efficient Supported Liquid Extraction (SLE) protocol for the simultaneous extraction of 25-OH and 1, α25 di-OH-vitamin D2 and D3 metabolites from serum prior to LC-MS/MS analysis.

This application note describes the extraction of the immunosuppressant drug mycophenolic acid and its metabolite mycophenolic acid glucuronide from fortified serum using ISOLUTE SLE+ in a 96-well plate format.

This application note describes the solid phase extraction of a variety of basic drugs in urine which are typically screened for forensic toxicology panels using EVOLUTE® EXPRESS CX in a 10 mg 96-well plate format.

This application note describes a novel sample cleanup strategy to address the complex matrix effects associated with commercial milk product variables while maintaining adequate analyte recovery and repeatability